Evidence map›Paper›PMID 40992888›Full record

ReviewBMJ open respiratory research2025

Practical guide to management after an acute pulmonary embolism.

Raza Alikhan, Luke S Howard, Martin Johnson, Shruti Sweeney, David G Kiely, Joanna Pepke-Zaba

Abstract readReview
In one paragraph

Review in BMJ open respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raza AlikhanDivision of Population Medicine, Cardiff University School of Medicine, Cardiff, UK Raza.Alikhan@wales.nhs.uk.ORCID http://orcid.org/0000-0001-8762-1149
Luke S HowardNational Pulmonary Hypertension Service, Hammersmith Hospital, London, UK.ORCID http://orcid.org/0000-0003-2822-210X
Martin JohnsonScottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK.
Shruti SweeneyMedical Affairs Department, Janssen-Cilag, High Wycombe, UK.
David G KielySheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Joanna Pepke-ZabaPulmonary Vascular Diseases Unit, National Pulmonary Hypertension Service, Royal Papworth Hospital, Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Follow-up after acute pulmonary embolism (PE) is important to assess recovery, consider the need for on-going anticoagulation and identify chronic thromboembolic pulmonary hypertension (CTEPH), a rare but serious complication of PE. 16 dilemmas in the follow-up of acute PE were identified by a steering committee of four pulmonologists and a haematologist with interest in PE and/or CTEPH. Current literature was reviewed and a practical approach suggested based on expert consensus. Dilemmas discussed included: (1) how to manage a breathless patient; (2) what to do if CTEPH is suspected; (3) the difference between CTEPH and post-PE syndrome, (4) testing for thrombophilia, (5) when to investigate for cancer, (6) anticoagulation duration and dose, (7) approaches to discussions and decision-making with respect to anticoagulation, (8) use of aspirin and whether antiplatelet therapy should be stopped during anticoagulation and (9) advice for patients on discharge from hospital at 3 months and information for first-degree relatives. Given the occurrence of complications that may require assessment, follow-up of patients post-PE should be systematic and consider the individual needs of the patient.

Indexed as

AnticoagulantsHypertension, PulmonaryPulmonary EmbolismAcute DiseaseDyspneaHumansPlatelet Aggregation InhibitorsPractice Guidelines as TopicThrombophiliaAnticoagulantsPlatelet Aggregation InhibitorsPulmonary Embolism

Identifiers

PMID40992888
PMCPMC12458777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.